RxDoctor Payments Data

Robert Hill, MD

Internal Medicine · Sandusky, OHNPI 1366470106

Payments from drug & device makers

$2,479in general payments, 2019–2025

Across 142 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$183
  • Boehringer Ingelheim$161
  • Pfizer$97
  • Otsuka America Pharmaceutical, Inc.$83
  • Exact Sciences$60
  • plus $508 from 16 others

What the payments were for

  • Food & beverage$2,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,479 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$206,169
Medicare patients
620
Services billed
2,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$173,480
JardianceEmpagliflozin116$116,335
JanuviaSitagliptin Phosphate88$110,483
OzempicSemaglutide72$110,096
Trelegy ElliptaFluticasone/Umeclidin/Vilanter100$84,281
RybelsusSemaglutide41$69,857
XareltoRivaroxaban60$67,987
CreonLipase/Protease/Amylase16$62,206
JanumetSitagliptin Phos/Metformin Hcl40$43,003
Lantus SolostarInsulin Glargine,hum.Rec.Anlog92$22,629
MounjaroTirzepatide19$18,714
Breo ElliptaFluticasone/Vilanterol31$17,521
Rosuvastatin Calcium859$14,503
LinzessLinaclotide15$13,510
MyrbetriqMirabegron14$11,548

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$183$179,953113 claims
PfizerEliquis$97$173,480129 claims
MerckJanuvia, Janumet$27$153,486128 claims
Boehringer IngelheimJardiance$161$116,335116 claims
GSKTrelegy Ellipta, Breo Ellipta$40$101,803131 claims
AbbVieCreon, Linzess, Synthroid$1,386$81,172213 claims
Lilly USA, LLCMounjaro$34$18,71419 claims
AstraZenecaBreztri Aerosphere, Symbicort$58$15,20746 claims
Astellas Pharma US IncMyrbetriq$41$11,54814 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$7,500668 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →